Development and validation of a patient-reported outcome instrument in partial responders to proton pump inhibitors

References

• El-Serag H, Becher A, Jones R. Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies. Aliment Pharmacol Ther 2010;32:720–37.
   PubMed Web of Science ®Google Scholar
• Fass R, Shapiro M, Dekel R, Sewell J. Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease – where next? Aliment Pharmacol Ther 2005;22:79–94.
   PubMed Web of Science ®Google Scholar
• Lehmann A. New pharmacological concepts in the treatment of gastro-oesophageal reflux disease. Eur Gastroenterol Hepatol Rev 2010;6:100–4.
   Google Scholar
• Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 2012;108:308–28.
   Google Scholar
• Patient-reported outcome measures: use in medical product development to support labeling claims Rockville, USA: Food and Drug Administration, 2009. Available from http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf. Accessed 29 January 2013.
   Google Scholar
• Shaw M, Dent J, Beebe T, Junghard O, Wiklund I, Lind T, et al. The Reflux Disease Questionnaire: a measure for assessment of treatment response in clinical trials. Health Qual Life Outcomes 2008;6:31.
   PubMed Web of Science ®Google Scholar
• Shaw MJ, Talley NJ, Beebe TJ, Rockwood T, Carlsson R, Adlis S, et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 2001;96:52–7.
   PubMed Web of Science ®Google Scholar
• Vakil N, Bjorck K, Denison H, Halling K, Karlsson M, Paty J, et al. Validation of the reflux symptom questionnaire electronic diary in partial responders to proton pump inhibitor therapy. Clin Transl Gastroenterol 2012;3:e7.
   PubMed Web of Science ®Google Scholar
• Svedlund J, Sjodin I, Dotevall G. GSRS – a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988;33:129–34.
   PubMed Web of Science ®Google Scholar
• Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995;30:1046–52.
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR. Methods to explain the clinical significance of health status measures. Mayo Clin Proc 2002;77:371–83.
   PubMed Web of Science ®Google Scholar
• Robinson M, Sahba B, Avner D, Jhala N, Greski-Rose PA, Jennings DE. A comparison of lansoprazole and ranitidine in the treatment of erosive oesophagitis. Multicentre Investigational Group. Aliment Pharmacol Ther 1995;9:25–31.
   PubMed Web of Science ®Google Scholar
• Fayers PM, Machin D. Quality of life: assessment, analysis and interpretation. edition. Wiley; Chichester: 2000.
   Google Scholar
• Fleiss JL. The design and analysis of clinical experiments. Wiley classics library edition. Wiley; New York: 1999.
   Google Scholar
• Vakil NB, Halling K, Becher A, Rydén A. Systematic review of patient-reported outcome instruments for gastroesophageal reflux disease symptoms. Eur J Gastroenterol Hepatol 2013;25:2–14.
   PubMed Web of Science ®Google Scholar
• Veldhuyzen van Zanten S, Armstrong D, Barkun A, Junghard O, White RJ, Wiklund IK. Symptom overlap in patients with upper gastrointestinal complaints in the Canadian confirmatory acid suppression test (CAST) study: further psychometric validation of the Reflux Disease Questionnaire. Aliment Pharmacol Ther 2007;25:1087–97.
   PubMedGoogle Scholar
• Bredenoord AJ, Weusten BL, Timmer R, Smout AJ. Air swallowing, belching, and reflux in patients with gastroesophageal reflux disease. Am J Gastroenterol 2006;101:1721–6.
   PubMedGoogle Scholar
• Kessing BF, Bredenoord AJ, Velosa M, Smout AJ. Supragastric belches are the main determinants of troublesome belching symptoms in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2012; Epub ahead of print.
   PubMedGoogle Scholar
• Smith JA, Decalmer S, Kelsall A, McGuinness K, Jones H, Galloway S, et al. Acoustic cough-reflux associations in chronic cough: potential triggers and mechanisms. Gastroenterology 2010;139:754–62.
   PubMed Web of Science ®Google Scholar
• Liu JY, Woloshin S, Laycock WS, Rothstein RI, Finlayson SR, Schwartz LM. Symptoms and treatment burden of gastroesophageal reflux disease: validating the GERD assessment scales. Arch Intern Med 2004;164:2058–64.
   PubMedGoogle Scholar
• Thompson SK, Cai W, Jamieson GG, Zhang AY, Myers JC, Parr ZE, et al. Recurrent symptoms after fundoplication with a negative pH study--recurrent reflux or functional heartburn? J Gastrointest Surg 2009;13:54–60.
   PubMedGoogle Scholar
• Kahrilas PJ, Howden CW, Hughes N, Molloy-Bland M. Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease. Chest 2013;143:605–12.
   PubMed Web of Science ®Google Scholar
• Vaezi M. Chronic cough and gastroesophageal reflux disease: how do we establish a causal link? Chest 2013;143:587–90.
   PubMedGoogle Scholar
• Heading RC, Monnikes H, Tholen A, Schmitt H. Prediction of response to PPI therapy and factors influencing treatment outcome in patients with GORD: a prospective pragmatic trial using pantoprazole. BMC Gastroenterol 2011;11:52.
   PubMedGoogle Scholar
• Bytzer P. Goals of therapy and guidelines for treatment success in symptomatic gastroesophageal reflux disease patients. Am J Gastroenterol 2003;98:S31–9.
   PubMed Web of Science ®Google Scholar
• Bytzer P, van Zanten SV, Mattsson H, Wernersson B. Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis – a post hoc analysis of 5796 patients. Aliment Pharmacol Ther 2012;36:635–43.
   PubMed Web of Science ®Google Scholar
• Vakil N, Veldhuyzen van Zanten S, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastro-esophageal reflux disease (GERD) – a global evidence-based consensus. Am J Gastroenterol 2006;101:1900–20.
   PubMed Web of Science ®Google Scholar
• Dent J, Kahrilas PJ, Vakil N, Veldhuyzen van Zanten S, Bytzer P, Delaney B, et al. Clinical trial design in adult reflux disease – a methodological workshop. Aliment Pharmacol Ther 2008;28:107–26.
   PubMedGoogle Scholar